Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  MorphoSys AG    MOR   DE0006632003

MORPHOSYS AG

(MOR)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Most relevant news about MORPHOSYS AG
07/15The Galapagos drugs pipeline that has drawn in Gilead
RE
07/09MORPHOSYS AG : Notification and public disclosure of transactions by persons
EQ
07/08MORPHOSYS : and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibito..
PU
07/08MORPHOSYS : and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibito..
EQ
07/04MORPHOSYS : Ad hoc - MorphoSys Increases Financial Guidance for 2019 Following a..
AQ
07/04MORPHOSYS : Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilim..
AQ
07/03MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
07/03AD HOC : MorphoSys Increases Financial Guidance for 2019 Following a Milestone P..
EQ
07/03MORPHOSYS : Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilim..
EQ
06/28MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
06/26MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
06/25MORPHOSYS : Ad hoc - MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Exec..
AQ
06/24CORRECTION OF A RELEASE FROM 24/06/2 : 36 CET/CEST - Ad hoc: MorphoSys Appoints ..
EQ
06/24MORPHOSYS : Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer
EQ
06/24AD HOC : MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Office..
EQ
More most relevant news
All news about MORPHOSYS AG
07/15The Galapagos drugs pipeline that has drawn in Gilead
RE
07/09MORPHOSYS AG : Notification and public disclosure of transactions by persons
EQ
07/08MORPHOSYS : and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibito..
PU
07/08MORPHOSYS : and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibito..
EQ
07/04MORPHOSYS : Ad hoc - MorphoSys Increases Financial Guidance for 2019 Following a..
AQ
07/04MORPHOSYS : Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilim..
AQ
07/03MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
07/03AD HOC : MorphoSys Increases Financial Guidance for 2019 Following a Milestone P..
EQ
07/03MORPHOSYS : Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilim..
EQ
06/28MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
More news
Sector news : Biotechnology & Medical Research - NEC
11:37aGILEAD SCIENCES : Says Study of GS-6207 Showed HIV Capsid Inhibition Can Lead Vi..
DJ
08:54aGILEAD SCIENCES : Licenses Durect's Saber Technology for Injectable HIV Product
DJ
07/19Gilead Licenses Respiratory, Herpes Antiviral Research Programs From Novartis
DJ
07/17GILEAD SCIENCES : Chief Scientific Officer John McHutchison to Leave
DJ
07/16As steep patent cliff looms, Shionogi moves to develop its own U.S. sales sta..
RE
More sector news : Biotechnology & Medical Research - NEC
Upcoming event on MORPHOSYS AG